跳至主要内容
临床试验/NCT02211612
NCT02211612已完成不适用

Role of Fatty Acids in Skeletal Muscle Hypertrophy and Ectopic Fat Accumulation During Overfeeding (LIPOGAIN-2)

Uppsala University2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2014年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60
试验地点
2
主要终点
Change in lean tissue mass

研究概览

简要总结

To investigate metabolic and molecular response to fatty acid-specific overfeeding in overweight subjects, in relation to changes in ectopic fat, lean tissue mass and insulin sensitivity

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
30 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Body mass index 25-32

排除标准

  • Type 2 diabetes
  • Type 1 diabetes
  • Kidney disease
  • Liver disease
  • Abnormal clinical chemistry at screening
  • Intense physical exercise > 2 hours per week
  • Use of statins or drugs affecting energy metabolism
  • Use of extreme diets

结局指标

主要结局

Change in lean tissue mass

时间窗: 10 weeks

Assessed by magnetic resonance imaging (MRI) and air displacement plethysmography (BodPod)

次要结局

  • Change in hepatic fat content(10 weeks)
  • Change in visceral adipose tissue (VAT)(10 weeks)
  • Change in total adipose tissue(10 weeks)
  • Change in pancreatic fat(10 weeks)
  • Change in insulin sensitivity(10 weeks)
  • Change in plasma lipids(10 weeks)
  • Change in circulating inflammation and coagulation markers(10 weeks)

研究者

发起方
Uppsala University
申办方类型
Other
责任方
Principal Investigator
主要研究者

David Iggman

MD

Uppsala University

研究点 (2)

Loading locations...

相似试验